National Rheumatologist Round Table: Kickoff 2022 Rheumatology Hot Topics Webinar
Join American Rheumatology Network and TSI Healthcare on Tuesday, February 22 at 6:00 PM ET, as thought leaders in the Rheumatology industry converge to kick off 2022 discussing hot topics affecting practices nationwide. Topics will include:
Systemic Lupus Erythematosus (SLE) Updates
Measuring lupus disease activity in a non-research, community setting is difficult as the current disease activity measures are designed for research trials and are therefore complex and ill-suited for routine clinical use. Find out how to use informatics to help identify lupus patients who may have poor disease activity based on chronic glucocorticoid use and bring them to the clinician’s attention. The availability of new therapeutic agents is changing how clinicians conceptualize adequate disease control and have changed how lupus is viewed as a disease. We will review the specific disease manifestations that have been shown to respond to modern therapeutics and offer practical advice to clinicians on how these treatment paradigms are changing.
Preparing for MIPS Value Pathways—Coming to Rheumatology in 2023!
Value-based contracting continues to evolve, and CMS is planning MIPS-MVP for Rheumatology in 2023. We will discuss what this might look like, and how rheumatologists should prepare.
We will discuss how to employ informatics to ease the burden of identifying at-risk populations for screening, streamline collaboration with Pulmonary specialists, and improve patient outcomes.
Live Q & A
Let us hear from you! As part of your registration, we invite you to submit a question to our panelists. We will select questions to be addressed live during the Round Table. This webinar is available exclusively to community rheumatology practices. Secure your seat today by clicking below!
Steven D. Nathan, MD, MBBcH, FCCP
Medical Director, Advanced Lung Disease & Lung Transplant Program, Inova Fairfax Hospital, Falls Church, VA
Steven D. Nathan, MBBcH, FCCP, is Director of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital in Falls Church, Virginia and is a Professor at the University of Virginia. Dr. Nathan received his medical degree from the University of the Witwatersrand Medical School in Johannesburg, South Africa. Subsequently, he completed a residency in internal medicine at Long Island Jewish Hospital in New York and fellowships in pulmonary medicine, critical care and lung transplantation at Cedars-Sinai Medical Center in Los Angeles. Dr. Nathan has been at Inova Fairfax Hospital since 1996. Dr. Nathan has authored more than 500 publications, including original research manuscripts, abstracts, reviews, book chapters and three books on idiopathic pulmonary fibrosis. His main areas of research interest include interstitial lung disease, pulmonary hypertension, and lung transplantation. Dr. Nathan is a reviewer for multiple journals and is on the editorial board for the journal Thorax. He co-chaired the 6th World Symposium task force for group 3 pulmonary hypertension. He has served on multiple committees, including data safety and monitoring committees and steering committees for clinical trials, where he has also served as chair. He has also served on multiple US Food and Drug Administration advisory boards and is currently the Chair of the FDA Anesthesiology and Respiratory Therapy Devices Panel. Dr. Nathan has delivered talks and served as chairperson of numerous sessions at many national and international conferences.
Jayson Slotnik, MPH, JD
Partner, Health Policy Strategies, LLC, Washington, DC
Jayson S. Slotnik is a Principal and founding member of Health Policy Strategies, Inc., a Washington, D.C. based consulting firm representing innovative biotech, pharmaceutical, device, and diagnostic companies.
Jayson specializes in, and counsels clients on, the impact that Medicare and Medicaid coverage, payment, reimbursement, coding, and government policies have on commercial success. He also has experience as a healthcare strategist with demonstrated success in developing and implementing both pre- and post-launch strategies as well as life cycle management tools for pharmaceutical, biotechnology, diagnostic, and device manufacturers.
Prior to establishing Health Policy Strategies, Inc., Jayson served as the Vice President of Reimbursement and Innovation Strategies for United BioSource Corporation (UBC) and practiced law at two prominent Washington, D.C. law firms where he counseled clients on many complex health care regulatory and legal issues related to coverage, coding and reimbursement. Before returning to private practice, Jayson served as in the initial Director of Medicare Reimbursement and Economic Policy at the Biotechnology Industry Organization (BIO), the industry’s leading advocacy group. Jayson served as the liaison between BIO and Congress, CMS, and other federal agencies to implement market access policies that stimulate and reward innovation while maintaining appropriate patient access to cutting edge therapies.
Donald Thomas, MD, FACP, FACR
Rheumatologist, Arthritis and Pain Associates of Prince Georges County, Greenbelt, MD, and Associate Professor of Medicine, Uniformed Services University, Bethesda, MD
Donald Thomas, MD, is an Associate Professor of Medicine at the Uniformed Services University, Bethesda, MD, and is in private practice in Greenbelt, MD, with a focus on lupus. He is the author of the Lupus Foundation’s seal-approved book The Lupus Encyclopedia from Johns Hopkins Press. He runs a lupus educational blog and Facebook Page called “The Lupus Encyclopedia” with close to 30,000 followers worldwide. He is a chair emeritus of the Medical and Scientific Advisory Board of the Lupus Foundation MidAtlantic chapter, received the Lupus Foundation’s Hero Award in 2016 from the MidAtlantic Chapter, and is current Chair of the National Board of Directors of the Sjögren’s Foundation.
Moderator & Panelist
Colin Edgerton, MD, FACP, FACR, RhMSUS
Rheumatologist, Low Country Rheumatology, and Executive Chairman, American Rheumatology Network
Dr. Edgerton is a practicing rheumatologist and the Executive Chairman of the American Rheumatology Network, a physician owned and led organization committed to improving healthcare by empowering independent rheumatology practices across the nation. He is also a founding member of Articularis Healthcare Group, Inc., the largest Rheumatology practice in the United States, spanning the states of Florida, South Carolina, Georgia, Alabama, Kentucky, North Carolina, Oklahoma, and Tennessee. He is a respected leader in value-based medicine and is nationally recognized for his work on treatment pathways and Alternative Payment Models, having testified to Congress and advised numerous stakeholders on the topic.